{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:04:06Z","timestamp":1783490646344,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA214890"],"award-info":[{"award-number":["R01CA214890"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA195568"],"award-info":[{"award-number":["U01CA195568"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.eclinm.2024.102959","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T01:52:12Z","timestamp":1732672332000},"page":"102959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1420-5563","authenticated-orcid":false,"given":"Jonathan W.","family":"Friedberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myla","family":"Strawderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad S.","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidore S.","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Reagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Casulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Averill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grerk","family":"Sutamtewagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Strang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-452X","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick R.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta J.","family":"Nastoupil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2024.102959_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/annonc\/mds517","article-title":"ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)","volume":"24","author":"Ghielmini","year":"2013","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.eclinm.2024.102959_bib2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.2014.57.5092","article-title":"Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation in SWOG and LYSA studies","volume":"33","author":"Kelly","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102959_bib3","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102959_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.70","article-title":"Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma","volume":"7","author":"Tracy","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.eclinm.2024.102959_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106308","article-title":"The impact of vitamin D on cancer: a mini review","volume":"231","author":"Seraphin","year":"2023","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"27","key":"10.1016\/j.eclinm.2024.102959_bib6","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102959_bib7","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","article-title":"Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte","volume":"15","author":"Brice","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102959_bib8","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.eclinm.2024.102959_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/biomet\/60.2.267","article-title":"Marginal likelihoods based on Cox's regression and life model","volume":"60","author":"Kalbfleisch","year":"1973","journal-title":"Biometrika"},{"issue":"28","key":"10.1016\/j.eclinm.2024.102959_bib10","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1200\/JCO.2014.56.5853","article-title":"Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402","volume":"32","author":"Kahl","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102959_bib11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/1389200223666220627104139","article-title":"Vitamin D metabolism gene polymorphisms and their associated disorders: a literature review","volume":"23","author":"Abouzid","year":"2022","journal-title":"Curr Drug Metab"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102959_bib12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00277-016-2723-x","article-title":"The FCGR3A polymorphism predicts the response to rituximab-based therapy in patients with non-Hodgkin lymphoma: a meta-analysis","volume":"95","author":"Liu","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.eclinm.2024.102959_bib13","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.01912","article-title":"Long-term follow-up of the RESORT study (E4402): a randomized phase III comparison of two different rituximab dosing strategies for low-tumor burden follicular lymphoma","author":"Kahl","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102959_bib14","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1200\/JCO.22.02327","article-title":"Randomized phase III trial evaluating subcutaneous rituximab for the first-line treatment of low-tumor burden follicular lymphoma: results of a LYSA study","volume":"41","author":"Cartron","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"6694","key":"10.1016\/j.eclinm.2024.102959_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.adh7954","article-title":"Vitamin D regulates microbiome-dependent cancer immunity","volume":"384","author":"Giampazolias","year":"2024","journal-title":"Science"},{"issue":"27","key":"10.1016\/j.eclinm.2024.102959_bib16","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1200\/JCO.2010.28.6674","article-title":"Vitamin D deficiency is associated with inferior event-free and overall survival in diffuse large B-cell lymphoma","volume":"28","author":"Drake","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.eclinm.2024.102959_bib17","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1182\/bloodadvances.2023011458","article-title":"Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment","volume":"8","author":"Tadmor","year":"2024","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102959_bib18","doi-asserted-by":"crossref","first-page":"751.e1","DOI":"10.1016\/j.jtct.2022.08.001","article-title":"Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma","volume":"28","author":"Nath","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.eclinm.2024.102959_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106580","article-title":"25-Hydroxy vitamin D deficiency predicts inferior prognosis in Hodgkin lymphoma","volume":"105","author":"Qin","year":"2021","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102959_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bjc.1993.406","article-title":"The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma","volume":"68","author":"Hickish","year":"1993","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102959_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hon.2827","article-title":"Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B-cell lymphoma","volume":"39","author":"Donati","year":"2021","journal-title":"Hematol Oncol"},{"issue":"29","key":"10.1016\/j.eclinm.2024.102959_bib22","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1200\/JCO.2013.53.4537","article-title":"Vitamin d deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab","volume":"32","author":"Bittenbring","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102959_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.1991.108","article-title":"Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma","volume":"63","author":"Raina","year":"1991","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102959_bib24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3945\/ajcn.2008.27189","article-title":"Vitamin D supplementation during Antarctic winter","volume":"89","author":"Smith","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"14","key":"10.1016\/j.eclinm.2024.102959_bib25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/jama.2019.2210","article-title":"Effect of vitamin D supplementation on relapse-free survival among patients with digestive tract cancers: the AMATERASU randomized clinical trial","volume":"321","author":"Urashima","year":"2019","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.eclinm.2024.102959_bib26","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1182\/bloodadvances.2023010559","article-title":"Vitamin C and D supplementation in acute myeloid leukemia","volume":"7","author":"Mouchel","year":"2023","journal-title":"Blood Adv"},{"issue":"17","key":"10.1016\/j.eclinm.2024.102959_bib27","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1158\/1078-0432.CCR-18-0483","article-title":"Vitamin D supplementation and survival of patients with non-small cell lung cancer: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Akiba","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"14","key":"10.1016\/j.eclinm.2024.102959_bib28","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2019.2402","article-title":"Effect of high-dose vs standard-dose vitamin D3 supplementation on progression-free survival among patients with advanced or Metastatic colorectal cancer: the SUNSHINE randomized clinical trial","volume":"321","author":"Ng","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102959_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3109\/10428194.2014.919633","article-title":"Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma","volume":"56","author":"Hutchinson","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102959_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00394-015-0859-4","article-title":"A\u00a0dose-response study of vitamin D3 supplementation in healthy Chinese: a 5-arm randomized, placebo-controlled trial","volume":"55","author":"Yao","year":"2016","journal-title":"Eur J Nutr"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102959_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0007114510003065","article-title":"Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation","volume":"105","author":"Elnenaei","year":"2011","journal-title":"Br J Nutr"},{"issue":"21","key":"10.1016\/j.eclinm.2024.102959_bib32","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1306357","article-title":"Vitamin D\u2013binding protein and vitamin D status of Black Americans and white Americans","volume":"369","author":"Powe","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102959_bib33","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMp1608005","article-title":"Vitamin D deficiency\u2013is there really a pandemic?","volume":"375","author":"Manson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.eclinm.2024.102959_bib34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.19.00010","article-title":"AUGMENT: a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma","volume":"37","author":"Leonard","year":"2019","journal-title":"J\u00a0Clin Oncol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024005388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024005388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:03:56Z","timestamp":1778904236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024005388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":34,"alternative-id":["S2589537024005388"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102959","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102959"}}